The role of CD8+ T cells in anticancer immunity is well established, however, it is currently not clear if CD4+ T cells induced by DC-based HHP lung cancer vaccine can contribute to or mediate significant anti-tumor effect [45]. This evidence concerns the gene CD8A and lung cancer.